Outcomes following liver transplantation for seronegative acute liver failure: Experience during a 12-year period with more than 100 patients

Liver Transplantation

Volumn 11, Issue 1, 2005, Pages 27-34

  Wigg, Alan J ^a,b   Gunson, Bridget K ^a   Mutimer, David J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; CAUCASIAN; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; ETHNOLOGY; FATTY LIVER; FEMALE; HOSPITAL SERVICE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; SEPSIS; SERODIAGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; ETHNIC GROUPS; FEMALE; HEPATITIS; HEPATITIS ANTIBODIES; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12344251906     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20289     Document Type: Article

References (23)

1. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003;23: 227-237.
2. Kuwada SK, Patel VM, Hollinger FB, Lin HJ, Yarbough PO, Wiesner RH, et al. Non-A, non-B fulminant hepatitis is also non-E and non-C. Am J Gastroenterol 1994;89:57-61.
3. Mutimer D, Shaw J, Neuberger J, McMaster P, Elias E. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Liver 1995; 36:433-436.
4. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 1996;347:1152.
5. Cossart Y. TTV a common virus, but pathogenic? [Comment]. Lancet 1998;352:164.
6. Gow PJ, Mutimer D. Non-A, non-B fulminant hepatic failure. [Comment]. Arch Intern Med 2001;161:1013-1014.
7. Ferraz ML, Silva AE, Macdonald GA, Tsarev SA, Di Biscelgie AM, Lucey MR. Fulminant hepatitis in patients undergoing liver transplantation: evidence for a non-A, non-B, non-C, non-D, and non-E syndrome. Liver Transpl Surg 1996;2:60-66.
8. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986;6:288-294.
9. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
10. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003;237:666-675 [discussion 675-676].
11. Devlin J, Wendon J, Heaton N, Tan KC, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology 1995;21:1018-1024.
12. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience [Comment]. Ann Surg 1995;222:109-119.
13. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275. [Erratum appears in Lancet 1993;342:1000].
14. Mutimer DJ, Ayres RC, Neuberger JM, Davies MH, Holguin J, Buckels JA, et al. Serious paracetamol poisoning and the results of liver transplantation. Gut 1994;35:809-814.
15. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, et al. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 1995;36:433-436.
16. Salizzoni M, Franchello A, Zamboni F, Ricchiuti A, Cocchis D, Fop F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003;16:486-493.
17. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9: 500-505.
18. Clavien P, Selzner M. Hepatic steatosis and transplantation. Liver Transpl 2002;8:980.
19. Mutimer DJ, Elias E. Liver transplantation for fulminant hepatic failure. Prog Liver Dis 1992;10:349-367.
20. Nair S, Fustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002; 359:287-293.
21. Devlin J, O'Grady JG, Tan KC, Calne RY, Williams R. Ethnic variations in patient and graft survival after liver transplantation. Identification of a new risk factor for chronic allograft rejection. Transplantation 1993;56:1381-1384.
22. Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: report of two cases and review of the literature. Am J Gastroenterol 1998;93:468-470.
23. Mohamed R, Hubscher SG, Mirza DF, Gunson B, Mutimer DJ. Posttransplantation chronic hepatitis in fulminant hepatic failure. Hepatology 1997;25:1003-1007.